| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥43.31B | +54.9% |
| Gross profit | ¥7.57B | — |
| Operating income | ¥5.69B | — |
| Net income | ¥5.17B | +187.5% |
| Gross margin | 17.5% | Net margin 11.9% |
| Revenue Q/Q | -2.8% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥35.74B | 82.5% |
| R&D | ¥1.13B | 2.6% |
| SG&A | ¥1.54B | 3.6% |
| Tax & other | ¥0.52B | 1.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
巨化股份 ・ 中国巨石 ・ 生益科技 ・ 兖矿能源 ・ 复星医药 ・ 南山铝业 ・ 海航控股 ・ 圆通速递 ・ 恒瑞医药 ・ 万华化学 ・ 恒力石化 ・ 江西铜业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies